FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity

Nature Neuroscience

Volumn 11, Issue 12, 2008, Pages 1402-1409

  Flajolet, Marc ^a   Wang, Zhongfeng ^b   Futter, Marie ^a   Shen, Weixing ^b   Nuangchamnong, Nina ^a   Bendor, Jacob ^a   Wallach, Iwona ^a   Nairn, Angus C ^a,c   Surmeier, D James ^b   Greengard, Paul ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; MORPHOGENESIS; NERVE CELL PLASTICITY; NEURITE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPINE;

ADENOSINE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CYCLIC AMP; EMBRYO, MAMMALIAN; FIBROBLAST GROWTH FACTORS; HIPPOCAMPUS; IMMUNOPRECIPITATION; LONG-TERM POTENTIATION; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEURITES; NEURONS; PATCH-CLAMP TECHNIQUES; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, ADENOSINE A2A; RECEPTORS, FIBROBLAST GROWTH FACTOR; SYNAPSES; TRANSFECTION; TRIAZINES; TRIAZOLES; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 56749150875     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn.2216     Document Type: Article

References (48)

1. Fredholm, B.B. Purinoceptors in the nervous system. Pharmacol. Toxicol. 76, 228-239 (1995).
2. Zimmermann, H. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog. Neurobiol. 49, 589-618 (1996).
3. Lindskog, M. et al. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418, 774-778 (2002).
4. Durcan, M.J. & Morgan, P.F. Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice. Eur. J. Pharmacol. 168, 285-290 (1989).
5. Fuxe, K. et al. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J. Neural Transm. 114, 49-75 (2007).
6. Ornitz, D.M. & Itoh, N. Fibroblast growth factors. Genome Biol. 2, 3005.1-3005.12 (2001).
7. Dono, R. Fibroblast growth factors as regulators of central nervous system development and function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R867-R881 (2003).
8. Reuss, B. von Bohlen und Halbach, O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 313, 139-157 (2003).
9. Umemori, H., Linhoff, M.W., Ornitz, D.M. & Sanes, J.R. FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain. Cell 118, 257-270 (2004).
10. Forget, C., Stewart, J. & Trudeau, L.E. Impact of basic FGF expression in astrocytes on dopamine neuron synaptic function and development. Eur. J. Neurosci. 23, 608-616 (2006).
11. Fumagalli, F., Di Pasquale, L., Caffino, L., Racagni, G. & Riva, M.A. Stress and cocaine interact to modulate basic fibroblast growth factor (FGF-2) expression in rat brain. Psychopharmacology (Berl). 196, 357-364 (2007).
12. Grothe, C. & Timmer, M. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system. Brain Res. Rev. 54, 80-91 (2007).
13. Claus, P., Werner, S., Timmer, M. & Grothe, C. Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease. Neurosci. Lett. 360, 117-120 (2004).
14. Mohammadi, M. et al. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol. Cell. Biol. 11, 5068-5078 (1991).
15. Sorokin, A., Mohammadi, M., Huang, J. & Schlessinger, J. Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766. J. Biol. Chem. 269, 17056-17061 (1994).
16. Hayashi, H., Ishisaki, A., Suzuki, M. & Imamura, T. BMP-2 augments FGF-induced differentiation of PC12 cells through upregulation of FGF receptor 1 expression. J. Cell Sci. 114, 1387-1395 (2001).
17. Kobayashi, S. & Millhorn, D.E. Stimulation of expression for the adenosine A2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection. J. Biol. Chem. 274, 20358-20365 (1999).
18. Vaudry, D., Stork, P.J., Lazarovici, P. & Eiden, L.E. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296, 1648-1649 (2002).
19. Wu, G.Y., Deisseroth, K. & Tsien, R.W. Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology. Nat. Neurosci. 4, 151-158 (2001).
20. Goldin, M. & Segal, M. Protein kinase C and ERK involvement in dendritic spine plasticity in cultured rodent hippocampal neurons. Eur. J. Neurosci. 17, 2529-2539 (2003).
21. Alonso, M., Medina, J.H. & Pozzo-Miller, L. ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn. Mem. 11, 172-178 (2004).
22. d'Alcantara, P., Ledent, C., Swillens, S. & Schiffmann, S.N. Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission. Neuroscience 107, 455-464 (2001).
23. Thomas, G.M. & Huganir, R.L. MAPK cascade signaling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173-183 (2004).
24. Surmeier, D.J., Ding, J., Day, M., Wang, Z. & Shen, W. D1 and D2 dopamine- receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 30, 228-235 (2007).
25. Calabresi, P., Picconi, B., Tozzi, A. & Di Filippo, M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 30, 211-219 (2007).
26. Lee, S.P., O'Dowd, B.F. & George, S.R. Homo- and hetero- oligomerization of G protein-coupled receptors. Life Sci. 74, 173-180 (2003).
27. Schlessinger, J. Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 13, 443-447 (1988).
28. Jahangeer, S. & Rodbell, M. The disaggregation theory of signal transduction revisited: further evidence that G proteins are multimeric and disaggregate to monomers when activated. Proc. Natl. Acad. Sci. USA 90, 8782-8786 (1993).
29. Thomason, P.A., Wolanin, P.M. & Stock, J.B. Signal transduction: receptor clusters as information processing arrays. Curr. Biol. 12, R399-R401 (2002).
30. Ferguson, S.S. Receptor tyrosine kinase transactivation: fine-tuning synaptic transmission. Trends Neurosci. 26, 119-122 (2003).
31. Shah, B.H. & Catt, K.J. GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences. Trends Neurosci. 27, 48-53 (2004).
32. Claus, P., Werner, S., Timmer, M. & Grothe, C. Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease. Neurosci. Lett. 360, 117-120 (2004).
33. Valjent, E. et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. USA 102, 491-496 (2005).
34. Ding, J., Peterson, J.D. & Surmeier, D.J. Corticostriatal and thalamostriatal synapses have distinctive properties. J. Neurosci. 28, 6483-5492 (2008).
35. Tepper, J.M., Wilson, C.J. & Koos, T. Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons. Brain Res. Rev. 58, 272-281 (2007).
36. Calabresi, P., Picconi, B., Tozzi, A. & Di Filippo, M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 30, 211-219 (2007).
37. 2+ channels in rat striatal cholinergic interneurons. J. Neurophysiol. 83, 322-332 (2000).
38. Ferre, S., Fredholm, B.B., Morelli, M., Popoli, P. & Fuxe, K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20, 482-487 (1997).
39. Ferre, S. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology (Berl.) 133, 107-120 (1997).
40. Centonze, D., Picconi, B., Gubellini, P., Bernardi, G. & Calabresi, P. Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur. J. Neurosci. 13, 1071-1077 (2001).
41. Kerr, J.N. & Wickens, J.R. Dopamine D-1/D-5 receptor activation is required for longterm potentiation in the rat neostriatum in vitro. J. Neurophysiol. 85, 117-124 (2001).
42. Surmeier, D.J., Song, W.J. & Yan, Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16, 6579-6591 (1996).
43. Gerfen, C.R. et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432 (1990).
44. Kreitzer, A.C. & Malenka, R.C. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J. Neurosci. 25, 10537-10545 (2005).
45. Song, B.W., Vinters, H.V., Wu, D. & Pardridge, W.M. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector. J. Pharmacol. Exp. Ther. 301, 605-610 (2002).
46. Flajolet, M. et al. A genomic approach of the hepatitis C virus generates a protein interaction map. Gene 242, 369-379 (2000).
47. Flajolet, M. et al. Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3. Proc. Natl. Acad. Sci. USA 100, 16006-16011 (2003).
48. Futter, M. et al. Phosphorylation of spinophilin by ERK and cyclin-dependent PK 5 (Cdk5). Proc. Natl. Acad. Sci. USA 102, 3489-3494 (2005).